SLXN

Silexion Therapeutics Corp Ordinary Shares

2.13

USD

SLXN Earnings Reports

Positive Surprise Ratio

SLXN beat 2 of 5 last estimates.

40%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -1 (Revenue/ EPS)

Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue

On Nov 12, 2025, SLXN reported earnings of -2.88 USD per share (EPS) for Q3 25, beating the estimate of -3.46 USD, resulting in a 16.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.56% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Silexion Therapeutics Corp Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$2.88, beating estimates by 16.96%, and revenue of $0.00, 0% as expectations.

How did the market react to Silexion Therapeutics Corp Ordinary Shares's Q3 2025 earnings?

The stock price moved up 3.56%, changed from $2.81 before the earnings release to $2.91 the day after.

When is Silexion Therapeutics Corp Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Silexion Therapeutics Corp Ordinary Shares's next earnings report?

Based on -- analysts, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.